Allscripts (MDRX) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Allscripts Announces Third Quarter 2020 Results
October 29, 2020 4:01 PM EDTThird quarter operating margin and Adjusted EBITDA margin increased both year-over-year and sequentially GAAP EPS of $0.00; 18% year-over-year growth in non-GAAP diluted EPS to $0.20 Generated $53 million of operating cash flow and $27 million of free cash flow in the third quarter
CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and nine months ended September 30, 2020.
Bookings(1) were $187 million in the third quarter of 2020. This result compares with $236 million in the third quarter of 2019. Contract revenue... More
